Skip to main content
. Author manuscript; available in PMC: 2022 Oct 22.
Published in final edited form as: Biomed Pharmacother. 2021 Mar 21;138:111426. doi: 10.1016/j.biopha.2021.111426

Fig. 1.

Fig. 1.

Effects of WSBCW on gastrointestinal health in normal situation. (A) Whole gut transit after one-week pretreatment, (B) small intestine motility of mice after two-week pretreatment, and (C) small intestinal permeability as measured by FL intensity of FITC-dextran permeated into the serum of mice. Within each panel, values with “*” are significantly different from that of the control; *p < 0.05, **p < 0.01, ***p < 0.001.